📜 iter-4360dd15-0008.log

56473 bytes

# Iter-0008  mission=4360dd15
# goal: 找到让人类长生不老的方法
# time: 2026-04-25T22:49:32
# focus_node: n116 :: 审计 type I interferon / JAK-STAT 是否是更高杠杆的免疫-衰老入口

========== TRANSCRIPT ==========
  → call task_view({"max_depth":6})

【tool:task_view】
{"ok": true, "tree": "GOAL: 找到让人类长生不老的方法\n· [✓ done       ] root: 找到让人类长生不老的方法\n├─   [✓ done       ] n1: 建立 marker 锚定后的局部交换判定框架   ← 已完成 marker 锚定后的局部交换判定框架:固定 μ 锚点、排除触及 μ 的交换、用 greedy witness span 压缩候选窗口,并在触及 wit\n│  ├─   [✓ done       ] n5: 规范化 witness:固定 μ 锚点并限制一次交换的位置   ← 完成 witness 规范化:确认固定 μ 锚点时必须排除触碰 μ 的交换,并用 greedy witness span 将允许交换压缩到局部窗口内;小规模穷举\n│  │  ├─   [✓ done       ] n9: 证伪一次交换跨越 μ 的规范化可能性   ← 用穷举验证并归纳出结构性事实:任何触及唯一 marker μ 的相邻交换都会使 μ 的位置改变 1,因此在固定 μ 位置的 witness 规范化里,不存在“跨\n│  │  ├─   [✓ done       ] n10: 把单侧交换位置压缩为可判定窗口   ← 证明并穷举验证:对左块 greedy witness 的最左/最右嵌入位置 p1..pk,窗口外相邻交换不会改变最大前缀消耗 k,因此允许交换位置可压缩为 [p\n│  │  └─   [✓ done       ] n11: 沉淀 witness 规范形模板   ← 沉淀出 witness 规范形模板:固定 μ 锚点、排除触及 μ 的交换、以 greedy witness span 限定局部窗口,并用左块最大前缀消耗 k 作\n│  ├─   [✓ done       ] n6: 建立单侧切分判定接口:把可行性压成存在切分点 k   ← 把固定 μ 锚点后的可行性压成了单侧切分接口:左块只通过最大前缀消耗长度 k 传递,且 k 由 X 决定、与 Y 无关。\n│  ├─   [✓ done       ] n7: 刻画交换不依赖右侧的充分条件   ← 验证了一个可复用充分条件:若一次相邻交换不改变对任意 S 的左块最大前缀消耗 k,则对所有右侧 Y 的可行性判定保持不变;并用穷举检查了 small-case \n│  ├─   [✓ done       ] n8: 沉淀可复用的验证模板与失败边界   ← 找到验证模板的失败边界:任意 witness span 不够,必须用 greedy witness span;给出反例 X=abb, S=ba,窗口外交换仍可改\n│  ├─   [✓ done       ] n12: 探索两次相邻交换下 greedy witness span 的局部性边界   ← 在二元字母表、长度 n<=8 的穷举中,未找到“两个相邻交换都发生在原始 greedy witness span 之外却改变 k”的反例;这给出了多交换局部性边\n│  ├─   [✓ done       ] n13: 把 marker 锚定后的局部交换判定落实为可执行的 O(n)~O(n log n) 检查流程   ← 完成了一个可执行的局部交换检查流程:先算 k,再用 greedy witness span 的局部闭包限制候选交换;对二元字母表、|X|<=8、|S|<=8 的\n│  ├─   [✓ done       ] n14: 证伪 greedy witne

  → call search_memory({"limit":8,"mission_only":true,"query":"type I interferon JAK STAT aging lifespan healthspan HSC exhaustion inflammaging upstream bottleneck"})

【tool:search_memory】
{"ok": true, "results": [{"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425144459000", "preview": "!! 下轮焦点(来自 mission `4360dd15` · Iter-0007)  [n116] 审计 type I interferon / JAK-STAT 是否是更高杠杆的免疫-衰老入口(路径:找到让人类长生不老的方法 > 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选 > 审计 type I interferon / JAK-STAT 是否是更高杠杆的免疫-衰老入口)"}, {"title": "先证支持集,再谈窗口判定", "tags": "lesson [[predicate verification]] [[boundary audit]] [[local insertion]]", "mission": "4360dd15", "modified": "20260424234005000", "preview": "当交换必须完全落在窗口内时,判定应写成 p-r<=i 且 i+1<=p+r,而不要只用 |i-p|<=r。"}, {"title": "把 inflammaging 当作回路读出而非单一瓶颈", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425041935000", "preview": "当一个衰老相关表型由多种刺激共同驱动、且疾病又会反过来放大它时,默认它是单一上游总开关通常是错误的。更稳妥的做法是先把它当作异质性读出/反馈回路,优先寻找可逆入口和可跨组织验证的功能恢复。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解

  → call search_memory({"limit":10,"mission_only":true,"query":"thymic source restoration immune upstream entry healthspan universal longevity bottleneck"})

  → call search_memory({"limit":10,"mission_only":true,"query":"cGAS-STING strong context-dependent aging node universal longevity bottleneck"})

  → call search_memory({"limit":10,"mission_only":true,"query":"type I interferon JAK STAT aging longevity bottleneck"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比对;不要用摘要、转述或片段印象下结论。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immu

【tool:search_memory】
{"ok": true, "results": [{"title": "NEXT_FOCUS", "tags": "pinned focus", "mission": "4360dd15", "modified": "20260425144459000", "preview": "!! 下轮焦点(来自 mission `4360dd15` · Iter-0007)  [n116] 审计 type I interferon / JAK-STAT 是否是更高杠杆的免疫-衰老入口(路径:找到让人类长生不老的方法 > 筛选免疫/炎症相关的下一个高杠杆长寿瓶颈候选 > 审计 type I interferon / JAK-STAT 是否是更高杠杆的免疫-衰老入口)"}, {"title": "先证支持集,再谈窗口判定", "tags": "lesson [[predicate verification]] [[boundary audit]] [[local insertion]]", "mission": "4360dd15", "modified": "20260424234005000", "preview": "当交换必须完全落在窗口内时,判定应写成 p-r<=i 且 i+1<=p+r,而不要只用 |i-p|<=r。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担

  → call search_memory({"limit":10,"mission_only":true,"query":"Thymic source restoration universal longevity bottleneck strong immune upstream entry emerging healthspan evidence immune-improving not yet longevity-proven"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比

  → call search_memory({"limit":5,"mission_only":true,"query":"Thymic source restoration is the top immune source-restoration entry"})

  → call search_memory({"limit":5,"mission_only":true,"query":"cGAS-STING is a strong but context-dependent aging node"})

【tool:search_memory】
{"ok": true, "results": [{"title": "Swap influence is confined to the greedy witness span", "tags": "lesson method [[predicate verification]] [[witness normalization]]", "mission": "4360dd15", "modified": "20260425011007000", "preview": "做局部编辑可行性验证时,先求出目标前缀的贪心嵌入,再只检查这段嵌入覆盖到的索引窗口;窗口外的相邻交换通常不会改变前缀消耗量或判定结果。把影响范围缩到 witness span,能把全局搜索压成可判定的局部验证。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比对;不要用摘要、转述或片段印象下结论。"}]}

【tool:search_memory】
{"ok": true, "results": [{"title": "序贯干预必须显式检索“先后顺序”", "tags": "lesson method evidence-chain", "mission": "4360dd15", "modified": "20260425031545000", "preview": "当要验证组合干预的因果顺序时,检索条件必须明确编码“先 A 后 B”,而不能只查两者同文共现。否则命中再多,也只能说明相关性,不能证明顺序证据。"}, {"title": "Swap influence is confined to the greedy witness span", "tags": "lesson method [[predicate verification]] [[witness normalization]]", "mission": "4360dd15", "modified": "20260425011007000", "preview": "做局部编辑可行性验证时,先求出目标前缀的贪心嵌入,再只检查这段嵌入覆盖到的索引窗口;窗口外的相邻交换通常不会改变前缀消耗量或判定结果。把影响范围缩到 witness span,能把全局搜索压成可判定的局部验证。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}]}

  → call search_memory({"limit":10,"mission_only":true,"query":"Thymic source restoration is the top immune source-restoration entry, but still not a universal longevity bottleneck"})

  → call search_memory({"limit":10,"mission_only":true,"query":"Thymic source restoration is a strong immune upstream entry with emerging healthspan evidence, but not yet a universal longevity bottleneck"})

  → call search_memory({"limit":10,"mission_only":true,"query":"Thymic source restoration is immune-improving, but not yet longevity-proven"})

【tool:search_memory】
{"ok": true, "results": [{"title": "Swap influence is confined to the greedy witness span", "tags": "lesson method [[predicate verification]] [[witness normalization]]", "mission": "4360dd15", "modified": "20260425011007000", "preview": "做局部编辑可行性验证时,先求出目标前缀的贪心嵌入,再只检查这段嵌入覆盖到的索引窗口;窗口外的相邻交换通常不会改变前缀消耗量或判定结果。把影响范围缩到 witness span,能把全局搜索压成可判定的局部验证。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "序贯干预必须显式检索“先后顺序”", "tags": "lesson method evidence-chain", "mission": "4360dd15", "modified": "20260425031545000", "preview": "当要验证组合干预的因果顺序时,检索条件必须明确编码“先 A 后 B”,而不能只查两者同文共现。否则命中再多,也只能说明相关性,不能证明顺序证据。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mis

【tool:search_memory】
{"ok": true, "results": [{"title": "序贯干预必须显式检索“先后顺序”", "tags": "lesson method evidence-chain", "mission": "4360dd15", "modified": "20260425031545000", "preview": "当要验证组合干预的因果顺序时,检索条件必须明确编码“先 A 后 B”,而不能只查两者同文共现。否则命中再多,也只能说明相关性,不能证明顺序证据。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 dif

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比对;不要用摘要、转述或片段印象下结论。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指

  → call search_memory({"limit":10,"mission_only":true,"query":"thymic source restoration top immune source-restoration entry longevity proven healthspan"})

  → call search_memory({"limit":10,"mission_only":true,"query":"cGAS-STING strong context-dependent aging node longevity validated universal"})

  → call search_memory({"limit":10,"mission_only":true,"query":"type I interferon JAK-STAT upstream inflammaging amplifier longevity healthspan"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比对;不要用摘要、转述或片段印象下结论。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immu

【tool:search_memory】
{"ok": true, "results": [{"title": "先证支持集,再谈窗口判定", "tags": "lesson [[predicate verification]] [[boundary audit]] [[local insertion]]", "mission": "4360dd15", "modified": "20260424234005000", "preview": "当交换必须完全落在窗口内时,判定应写成 p-r<=i 且 i+1<=p+r,而不要只用 |i-p|<=r。"}, {"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "把 inflammaging 当作回路读出而非单一瓶颈", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425041935000", "preview": "当一个衰老相关表型由多种刺激共同驱动、且疾病又会反过来放大它时,默认它是单一上游总开关通常是错误的。更稳妥的做法是先把它当作异质性读出/反馈回路,优先寻找可逆入口和可跨组织验证的功能恢复。"}]}

  → call search_memory({"limit":10,"mission_only":true,"query":"thymic source restoration"})

  → call search_memory({"limit":10,"mission_only":true,"query":"cGAS-STING strong but context-dependent aging node"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先取 XML 再谈差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230817000", "preview": "勘误核验必须先获取原始 XML/全文,再做逐词 diff;摘要或页面标题都不能当证据。"}, {"title": "先拿到原文再判定改动", "tags": "lesson erratum verification source-check", "mission": "4360dd15", "modified": "20260424230336000", "preview": "遇到更正/勘误时,必须先获取原文句子与更正句的完整文本,再做逐词比对,不能依赖摘要。"}, {"title": "先拿到原始 XML 再做差分", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230933000", "preview": "做勘误验证时,先定位原始 XML 中的完整原句与更正句,再进行逐词 diff,避免把整句替换误判成局部插入。"}, {"title": "先拿原文再做逐词 diff", "tags": "lesson [[erratum verification]] source-check text-diff", "mission": "4360dd15", "modified": "20260424230659000", "preview": "判断勘误类型必须以原始 XML 中的原句与更正句为准,再做逐词比对;不要用摘要、转述或片段印象下结论。"}]}

【tool:search_memory】
{"ok": true, "results": [{"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425050740000", "preview": "筛选长寿瓶颈时,不要把“看起来更上游”当作高杠杆的充分条件;真正更值得优先的靶点,是那些被扰动后能同时恢复多个下游功能、并最好有健康寿命或寿命终点支持的节点。"}, {"title": "免疫长寿入口的上游性排序", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425050322000", "preview": "在比较免疫相关长寿候选时,优先按因果上游性排序:补给源恢复 > 外周质量控制 > 局部 niche 维护。越接近补给源,越可能影响系统级健康寿命;只改善外周读出或局部环境,通常仍应视为下游入口而非最终瓶颈。"}, {"title": "优先寻找“可逆上游入口”而不是只看年龄读出", "tags": "lesson principle aging immunology", "mission": "4360dd15", "modified": "20260425041000000", "preview": "当一个候选机制不仅相关,而且能在原始研究里被上游干预逆转并带来功能恢复时,它就从“相关标志物”升级为“可干预瓶颈”。筛选长寿入口时,优先找这种同时满足可逆性、上游性和功能读出的靶点。"}, {"title": "老化干预要先

  → call pubmed_search({"limit":8,"query":"(type I interferon OR interferon alpha OR interferon beta) aging lifespan healthspan mice"})

  → call pubmed_search({"limit":8,"query":"JAK-STAT aging lifespan healthspan mice interferon"})

  → call pubmed_search({"limit":8,"query":"type I interferon hematopoietic stem cell aging exhaustion mouse"})

  → call pubmed_search({"limit":8,"query":"interferon alpha blockade aging mouse healthspan lifespan"})

【tool:pubmed_search】
{"ok": true, "query": "(type I interferon OR interferon alpha OR interferon beta) aging lifespan healthspan mice", "results": [{"pmid": "28556428", "title": "Identification of tissue-specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics.", "source": "Aging Cell", "pubdate": "2017 Aug", "authors": ["Barger JL", "Vann JM", "Cray NL", "Pugh TD", "Mastaloudis A", "Hester SN", "Wood SM", "Newton MA"], "url": "https://pubmed.ncbi.nlm.nih.gov/28556428/"}]}

【tool:pubmed_search】
{"ok": true, "query": "JAK-STAT aging lifespan healthspan mice interferon", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "type I interferon hematopoietic stem cell aging exhaustion mouse", "results": [{"pmid": "31527834", "title": "PTPN2 regulates the generation of exhausted CD8(+) T cell subpopulations and restrains tumor immunity.", "source": "Nat Immunol", "pubdate": "2019 Oct", "authors": ["LaFleur MW", "Nguyen TH", "Coxe MA", "Miller BC", "Yates KB", "Gillis JE", "Sen DR", "Gaudiano EF"], "url": "https://pubmed.ncbi.nlm.nih.gov/31527834/"}]}

【tool:pubmed_search】
{"ok": true, "query": "interferon alpha blockade aging mouse healthspan lifespan", "results": []}

  → call search_memory({"limit":10,"mission_only":true,"query":"cGAS-STING universal longevity bottleneck aging node"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immu

  → call web_search({"limit":8,"query":"site:pubmed.ncbi.nlm.nih.gov type I interferon aging mouse lifespan healthspan interferon alpha beta"})

  → call web_search({"limit":8,"query":"site:pubmed.ncbi.nlm.nih.gov JAK-STAT aging mouse lifespan healthspan interferon"})

  → call web_search({"limit":8,"query":"site:pubmed.ncbi.nlm.nih.gov interferon blockade aging mouse healthspan lifespan"})

  → call web_search({"limit":8,"query":"site:pubmed.ncbi.nlm.nih.gov type I interferon hematopoietic stem cell aging mouse"})

【tool:web_search】
{"ok": false, "error": "timed out"}

【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}

【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}

【tool:web_search】
{"ok": false, "error": "[Errno 101] Network is unreachable"}

  → call search_memory({"limit":10,"mission_only":true,"query":"cGAS-STING strong but context-dependent aging node not yet validated universal longevity bottleneck"})

【tool:search_memory】
{"ok": true, "results": [{"title": "先确认研究类型再谈终点", "tags": "lesson audit study-design endpoint", "mission": "4360dd15", "modified": "20260424202124000", "preview": "先用题名和摘要把 review、trial、feasibility pilot 迅速分开,再按主要终点判断是否属于 longevity。"}, {"title": "先用终点语境判定是否真是长寿证据", "tags": "lesson classification endpoint trial-registry longevity", "mission": "4360dd15", "modified": "20260424203253000", "preview": "看到 survival 词也要先看语境;PFS、疾病量表、RTI、feasibility/safety 都不能默认算直接长寿终点。"}, {"title": "先锁定原始试验再谈终点", "tags": "lesson evidence-chain clinical-trials longevity", "mission": "4360dd15", "modified": "20260424205610000", "preview": "面对综述,先从参考文献中抽取一个未审计的原始人类试验 PMID,再只核实其主要终点是否直接指向死亡、生存、健康寿命或失能自由生存。"}, {"title": "senolysis 可能破坏有益的再生 niche", "tags": "lesson principle aging reprogramming", "mission": "4360dd15", "modified": "20260425032437000", "preview": "不要默认清除衰老细胞一定提升重编程或再生效率;在某些组织里,senescence/SASP 可能充当 pro-regenerative niche。任何 senolytic+重编程策略都必须先验证该组织中衰老信号是负担还是必要支持。"}, {"title": "寿命终点优先于通路热度", "tags": "lesson principle aging triage", "mission": "4360dd15", "modified": "20260425131208000", "preview": "筛选长寿靶点时,应把“是否直接延长寿命/健康寿命”作为高优先级门槛,而不是仅凭炎症强度、通路中心性或组织表型下结论。只有触及寿命终点的节点,才值得从“机制相关”升级为“候选干预靶点”。"}, {"title": "把干预时窗对齐到修复亚阶段", "tags": "lesson principle wound-healing reprogramming aging", "mission": "4360dd15", "modified": "20260425033646000", "preview": "组织修复不是单一状态,而是可分解的阶段化细胞程序;任何再生或重编程干预都应先对齐到具体亚阶段,再判断它是在增强急性修复接力,还是在纠正慢性失败断裂。"}, {"title": "按因果广度而不是表面上游性来排长寿瓶颈", "tags": "lesson principle aging immu

  → call pubmed_search({"limit":10,"query":"IFNAR1 aging mouse hematopoietic stem cell"})

  → call pubmed_search({"limit":10,"query":"type I interferon hematopoietic stem cell rejuvenation aging mouse IFNAR1"})

  → call pubmed_search({"limit":10,"query":"JAK inhibitor aging mouse healthspan interferon"})

  → call pubmed_search({"limit":10,"query":"type I interferon aging review mouse lifespan"})

  → call pubmed_search({"limit":10,"query":"interferon alpha beta stem cell aging mouse review"})

【tool:pubmed_search】
{"ok": true, "query": "IFNAR1 aging mouse hematopoietic stem cell", "results": [{"pmid": "36724510", "title": "Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis.", "source": "Blood Adv", "pubdate": "2023 Jun 13", "authors": ["Li Y", "Yang W", "Wang HC", "Patel RM", "Casey EB", "Denby E", "Magee JA"], "url": "https://pubmed.ncbi.nlm.nih.gov/36724510/"}, {"pmid": "35037428", "title": "PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response.", "source": "Adv Sci (Weinh)", "pubdate": "2022 Mar", "authors": ["Geng X", "Zhang C", "Li M", "Wang J", "Ji F", "Feng H", "Xing M", "Li F"], "url": "https://pubmed.ncbi.nlm.nih.gov/35037428/"}]}

【tool:pubmed_search】
{"ok": true, "query": "type I interferon hematopoietic stem cell rejuvenation aging mouse IFNAR1", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "JAK inhibitor aging mouse healthspan interferon", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "type I interferon aging review mouse lifespan", "results": []}

【tool:pubmed_search】
{"ok": true, "query": "interferon alpha beta stem cell aging mouse review", "results": []}

  → call pubmed_search({"limit":10,"query":"type I interferon aging stem cell inflammation"})

  → call pubmed_search({"limit":10,"query":"type I interferon senescence aging mouse"})

  → call pubmed_search({"limit":10,"query":"IFNAR1 aging stem cell"})

  → call pubmed_search({"limit":10,"query":"interferon signaling aging stem cells"})

  → call pubmed_search({"limit":10,"query":"interferon type I aging hematopoiesis review"})

【tool:pubmed_search】
{"ok": true, "query": "type I interferon aging stem cell inflammation", "results": [{"pmid": "41991686", "title": "p21(+)TREM2(+) senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.", "source": "Nat Aging", "pubdate": "2026 Apr", "authors": ["Salladay-Perez IA", "Avila I", "Estrada L", "Alexandru AC", "Ponce C", "Dhingra A", "Torres G", "Deng CY"], "url": "https://pubmed.ncbi.nlm.nih.gov/41991686/"}, {"pmid": "41760600", "title": "STING activation induces polarized cytokine secretion of IFN-β and IL-17A promoting photoreceptor death and choroidal disruption in age-related macular degeneration.", "source": "Cell Death Dis", "pubdate": "2026 Feb 27", "authors": ["Huang C", "Babu VS", "Bammidi S", "Arnold JN", "Ebeling M", "Widmer G", "Strassburger P", "Lazendic M"], "url": "https://pubmed.ncbi.nlm.nih.gov/41760600/"}, {"pmid": "41571554", "title": "Integrative transcriptomic profiling links telomere dysfunction to cGAS-STING activation in heart failure signatures in mice and humans.", "source": "Cardiovasc Res", "pubdate": "2026 Mar 26", "authors": ["Brandt M", "Khraisat S", "Luo Q", "Mayerle M", "Raaz U", "Tsao P", "Münzel T", "Lurz P"], "url": "https://pubmed.ncbi.nlm.nih.gov/41571554/"}, {"pmid": "38937070", "title": "Haematopoietic stem cell-derived immune cells have reduced X chromosome inactivation skewing in systemic lupus erythematosus.", "source": "Ann Rheum Dis", "pubdate": "2024 Sep 30", "authors": ["Roberts AL", "Mor

【tool:pubmed_search】
{"ok": true, "query": "type I interferon senescence aging mouse", "results": [{"pmid": "41991686", "title": "p21(+)TREM2(+) senescent macrophages fuel inflammaging and metabolic dysfunction-associated steatotic liver disease.", "source": "Nat Aging", "pubdate": "2026 Apr", "authors": ["Salladay-Perez IA", "Avila I", "Estrada L", "Alexandru AC", "Ponce C", "Dhingra A", "Torres G", "Deng CY"], "url": "https://pubmed.ncbi.nlm.nih.gov/41991686/"}, {"pmid": "41906618", "title": "Irgm1 Restrains CD8(+) T Cell Cytokine Production and Apoptosis via Cell-Extrinsic Regulation of Type I Interferon Signaling.", "source": "Eur J Immunol", "pubdate": "2026 Apr", "authors": ["Molloy CT", "Alwarawrah Y", "Cohen JA", "Fee BE", "Whitmire JK", "Taylor GA", "MacIver NJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/41906618/"}, {"pmid": "41850941", "title": "Inhibition of the type I interferon receptor pathway protects against muscle weakness induced by dermatomyositis serum.", "source": "Ann Rheum Dis", "pubdate": "2026 Mar 17", "authors": ["Kaewin S", "Leijding C", "Gastaldello S", "Makari D", "Zhong Y", "Andreasson KM", "Jardemark K", "Dastmalchi M"], "url": "https://pubmed.ncbi.nlm.nih.gov/41850941/"}, {"pmid": "41816335", "title": "MiR-34a deficiency enhances nucleic acid sensing and type I IFN signaling in a mouse model of Alzheimer's disease.", "source": "Front Immunol", "pubdate": "2026", "authors": ["Yang J", "Tsourdinis GE", "Holas C", "Maienschein-Cline M", "Lalonde R", "Fukuchi KI"], "ur

【tool:pubmed_search】
{"ok": true, "query": "IFNAR1 aging stem cell", "results": [{"pmid": "36724510", "title": "Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis.", "source": "Blood Adv", "pubdate": "2023 Jun 13", "authors": ["Li Y", "Yang W", "Wang HC", "Patel RM", "Casey EB", "Denby E", "Magee JA"], "url": "https://pubmed.ncbi.nlm.nih.gov/36724510/"}, {"pmid": "35037428", "title": "PICH Supports Embryonic Hematopoiesis by Suppressing a cGAS-STING-Mediated Interferon Response.", "source": "Adv Sci (Weinh)", "pubdate": "2022 Mar", "authors": ["Geng X", "Zhang C", "Li M", "Wang J", "Ji F", "Feng H", "Xing M", "Li F"], "url": "https://pubmed.ncbi.nlm.nih.gov/35037428/"}, {"pmid": "29622580", "title": "Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells.", "source": "Cancer Immunol Res", "pubdate": "2018 Jun", "authors": ["Castiello L", "Sestili P", "Schiavoni G", "Dattilo R", "Monque DM", "Ciaffoni F", "Iezzi M", "Lamolinara A"], "url": "https://pubmed.ncbi.nlm.nih.gov/29622580/"}, {"pmid": "25921537", "title": "DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function.", "source": "Cell Rep", "pubdate": "2015 May 5", "authors": ["Yu Q", "Katlinskaya YV", "Carbone CJ", "Zhao B", "Katlinski KV", "Zheng H", "Guha M", "Li N"], "url": "https://pubmed.ncbi.nlm.nih.gov/25921537/"}, {"pmid": "21446050", "title": "Activation of interferon signaling pathways in spinal cord astrocytes from

【tool:pubmed_search】
{"ok": true, "query": "interferon signaling aging stem cells", "results": [{"pmid": "42007500", "title": "Maladaptive Inflammatory Signaling in Old Mice Impairs Colonic Regeneration by Promoting a Sustained Fetal-Like Epithelial State.", "source": "Aging Cell", "pubdate": "2026 May", "authors": ["Korcari A", "Tauc H", "Duggan J", "Yun J", "Wehbe F", "Darmanis S", "Modrusan Z", "Pappu R"], "url": "https://pubmed.ncbi.nlm.nih.gov/42007500/"}, {"pmid": "41656949", "title": "Intranasal Human NSC-Derived EVs Therapy Can Restrain Inflammatory Microglial Transcriptome, and NLRP3 and cGAS-STING Signalling, in Aged Hippocampus.", "source": "J Extracell Vesicles", "pubdate": "2026 Feb", "authors": ["Madhu LN", "Kodali M", "Rao S", "Attaluri S", "Upadhya R", "Shankar G", "Shuai B", "Somayaji Y"], "url": "https://pubmed.ncbi.nlm.nih.gov/41656949/"}, {"pmid": "41364527", "title": "Rare epigenetic alterations are conserved across hematopoietic differentiation stages after mycobacterial infection.", "source": "JCI Insight", "pubdate": "2026 Jan 23", "authors": ["Tran BT", "Luna PN", "Cao R", "Le DT", "Thatavarty A", "Maneix L", "Kain BN", "Koh S"], "url": "https://pubmed.ncbi.nlm.nih.gov/41364527/"}, {"pmid": "41290566", "title": "Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury.", "source": "Signal Transduct Target Ther", "pubdate": "2025 Nov 26", "authors": ["Fischer JC", "Göttert S", "Giller M", "Heinrich P", "Fan K", "Khalid O", 

【tool:pubmed_search】
{"ok": true, "query": "interferon type I aging hematopoiesis review", "results": [{"pmid": "28471483", "title": "Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.", "source": "Arthritis Rheumatol", "pubdate": "2017 Aug", "authors": ["Gao L", "Bird AK", "Meednu N", "Dauenhauer K", "Liesveld J", "Anolik J", "Looney RJ"], "url": "https://pubmed.ncbi.nlm.nih.gov/28471483/"}]}

【assistant】
结论:**type I interferon / JAK-STAT 目前不能升级为“更高杠杆的免疫-衰老入口”**。  
本轮检索得到的证据主要是:

- **机制层面**:type I IFN 会推动衰老/干扰干细胞功能。最直接的例子是 **PMID 25921537**:`DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function`。
- **造血层面**:相关文献更多是在说它影响 HSC/免疫分化,而不是证明它是系统性长寿开关;例如 **PMID 36724510** 甚至显示 basal type I IFN 对新生/幼年造血影响“only modest”。
- **终点层面**:我没有检到 **type I IFN 或 JAK-STAT 的寿命/健康寿命直接证据**,也没有像 cGAS-STING 那样能把“上游性 + 功能恢复 + 更大尺度终点”串起来的强链条。

因此,当前最稳妥的判断是:

> **type I interferon / JAK-STAT = 上游炎症放大器与干细胞抑制轴,但尚不足以从“机制相关”升级为“通用长寿瓶颈”。**

相比之下,它更像是 **context-dependent 的下游执行层**,而不是比 cGAS-STING 更值得优先押注的系统级入口。

<NEXT_FOCUS>审计 complement cascade 是否能升级为更高杠杆的免疫-衰老入口</NEXT_FOCUS>

========== REFLECTION ==========
{
  "progress": "本轮只完成了对现有记忆与焦点的再审计:把下轮候选聚焦到 type I interferon / JAK-STAT,但还没有得到任何能升级为长寿瓶颈的新增证据。",
  "failure": "把搜索重心放在较宽泛的免疫-衰老关键词上,结果没有产出可判定的上游因果证据,更多是在重复已有的“先看寿命终点”框架。",
  "lesson": {
    "worthy": false,
    "title": "",
    "tags": [],
    "text": ""
  },
  "next_focus": "只审计 type I interferon / JAK-STAT 是否同时满足“可逆、跨组织、并且有直接寿命/健康寿命终点支持”这三个条件。"
}